StockNews.com assumed coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Free Report) in a research report report published on Sunday. The firm issued a hold rating on the stock. BiondVax Pharmaceuticals Stock Performance The company has a market capitalization of $2.54 million, a price-to-earnings ratio of -0.53 and a beta of 2.37. BiondVax Pharmaceuticals has […]
StockNews.com started coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Free Report) in a research note issued to investors on Friday morning. The firm issued a hold rating on the stock. BiondVax Pharmaceuticals Price Performance NASDAQ BVXV opened at $1.36 on Friday. BiondVax Pharmaceuticals has a 1 year low of $1.25 and a 1 year […]
StockNews.com assumed coverage on shares of BiondVax Pharmaceuticals (NASDAQ:BVXV – Free Report) in a report issued on Wednesday. The brokerage issued a hold rating on the stock. BiondVax Pharmaceuticals Price Performance Shares of BVXV opened at $1.32 on Wednesday. BiondVax Pharmaceuticals has a 12-month low of $1.25 and a 12-month high of $11.80. The firm […]
BiondVax Pharmaceuticals (NASDAQ:BVXV) Now Covered by StockNews com kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV – Get Free Report) saw a significant drop in short interest in July. As of July 31st, there was short interest totalling 3,600 shares, a drop of 25.0% from the July 15th total of 4,800 shares. Based on an average daily volume of 154,400 shares, the days-to-cover ratio is currently 0.0 […]